Top compounds associated with response to SIRPG


Feature Type Standardized
Nominal ANOVA
mRNA MG-132 CTRPv2 pan-cancer AAC -0.046 0.4
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.4
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.4
mRNA pitstop2 CTRPv2 pan-cancer AAC 0.035 0.4
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC 0.033 0.4
mRNA Repligen 136 CTRPv2 pan-cancer AAC 0.028 0.4
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.04 0.4
mRNA ML006 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA lapatinib CCLE pan-cancer AAC 0.036 0.4
mRNA MS-275 gCSI pan-cancer AAC 0.041 0.4
Download CSV